Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice - Dol-Gleizes, F; Paumelle, R; Visentin, V; Mares, A M; Desitter, P; Hennuyer, N; Gilde, A; Staels, B; Schaeffer, P; Bono, F (Arterioscler Thromb Vasc Biol, 2009)